Details for Patent: 12,453,756
✉ Email this page to a colleague
Which drugs does patent 12,453,756 protect, and when does it expire?
Patent 12,453,756 protects MOUNJARO, MOUNJARO (AUTOINJECTOR), ZEPBOUND, and ZEPBOUND (AUTOINJECTOR), and is included in two NDAs.
This patent has fifty-three patent family members in thirty-four countries.
Summary for Patent: 12,453,756
| Title: | GIP/GLP1 agonist compositions |
| Abstract: | A composition of tirzepatide, comprising an agent selected from NaCl and propylene glycol; and dibasic sodium phosphate is provided. |
| Inventor(s): | Vincent John Corvari, Christopher Sears Minie, Dinesh Shyamdeo Mishra, Ken Kangyi Qian |
| Assignee: | Eli Lilly and Co |
| Application Number: | US19/042,887 |
|
Patent Claim Types: see list of patent claims | Composition; Device; |
Drugs Protected by US Patent 12,453,756
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly And Co | MOUNJARO | tirzepatide | SOLUTION;SUBCUTANEOUS | 215866-007 | Jul 28, 2023 | RX | Yes | Yes | 12,453,756 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Eli Lilly And Co | MOUNJARO | tirzepatide | SOLUTION;SUBCUTANEOUS | 215866-008 | Jul 28, 2023 | RX | Yes | Yes | 12,453,756 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Eli Lilly And Co | MOUNJARO | tirzepatide | SOLUTION;SUBCUTANEOUS | 215866-009 | Jul 28, 2023 | RX | Yes | Yes | 12,453,756 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Eli Lilly And Co | MOUNJARO | tirzepatide | SOLUTION;SUBCUTANEOUS | 215866-010 | Jul 28, 2023 | RX | Yes | Yes | 12,453,756 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Eli Lilly And Co | MOUNJARO | tirzepatide | SOLUTION;SUBCUTANEOUS | 215866-011 | Jul 28, 2023 | RX | Yes | Yes | 12,453,756 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,453,756
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 115542 | ⤷ Start Trial | |||
| Australia | 2019289110 | ⤷ Start Trial | |||
| Australia | 2022279524 | ⤷ Start Trial | |||
| Australia | 2024266715 | ⤷ Start Trial | |||
| Brazil | 112020023452 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
